Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: corticotropin

« Back to Dashboard
Corticotropin is the generic ingredient in six branded drugs marketed by Parkedale, Sanofi Aventis Us, Organics Lagrange, Watson Labs, Mallinckrodt Ard, and Organon Usa Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for corticotropin. One supplier is listed for this compound.

Summary for Generic Name: corticotropin

Drug Master File Entries: see list10
Suppliers / Packaging: see list1

Pharmacology for Ingredient: corticotropin

Clinical Trials for: corticotropin

ACTHar in the Treatment of Lupus Nephritis
Status: Recruiting Condition: Lupus Nephritis

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Status: Active, not recruiting Condition: Diabetic Nephropathy

The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Status: Recruiting Condition: Rheumatoid Arthritis

Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Status: Completed Condition: Multiple Sclerosis (MS)

Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
Status: Recruiting Condition: Rheumatoid Arthritis

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organics Lagrange
INJECTABLE;INJECTION010831-002Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
INJECTABLE;INJECTION008317-004Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Mallinckrodt Ard
INJECTABLE;INJECTION008372-006Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn